E Erichsén1,2,3, A Milberg4,5,6, T Jaarsma4, M Friedrichsen4,6. 1. Department of Social and Welfare Studies, Linköping University, Norrköping, Sweden. eva.erichsen@liu.se. 2. Department of Advanced Home Care and Department of Social and Welfare Studies, Linköping University, Norrköping, Sweden. eva.erichsen@liu.se. 3. Palliative Education and Research Centre and Department of Social and Welfare Studies, Linköping University, Norrköping, Sweden. eva.erichsen@liu.se. 4. Department of Social and Welfare Studies, Linköping University, Norrköping, Sweden. 5. Department of Advanced Home Care and Department of Social and Welfare Studies, Linköping University, Norrköping, Sweden. 6. Palliative Education and Research Centre and Department of Social and Welfare Studies, Linköping University, Norrköping, Sweden.
Abstract
CONTEXT: For patients in palliative care, constipation is primarily a result of opioid treatment. Impacts from other factors related to constipation in palliative care are rarely studied. OBJECTIVES: The aim was to identify factors related to constipation in patients in palliative care, and then to compare these factors between patients with different types of constipation and patients without constipation. METHODS: Cross-sectional data on constipation was collected with a 26-item questionnaire from 485 patients in 38 specialist palliative care units in Sweden. Three different constipation groups were used; MC ONLY, PC ONLY, and MC & PC. Logistic regression analyses were used to calculate odds ratios. RESULTS: Patients with <3 defecations/week, MC ONLY, (n = 36) had higher odds of being hospitalized, bed-restricted, in need of personal assistance for toilet visits, and of having a poor fluid intake. Patients with the perception of being constipated, PC ONLY, (n = 93) had higher odds of having poor appetite, hemorrhoids, hard stool, more opioid treatment, less laxative treatment and of being more dissatisfied with constipation information. Patients with both <3 defecations/week and a perception of being constipated, MC & PC, (n = 78) had higher odds of having cancer- disease. CONCLUSION: There were several significant factors related to constipation with higher odds than opioid- treatment, for patients in palliative care, such as; hard stool, cancer diagnosis, dissatisfaction with information, low fluid intake, hemorrhoids, bed restriction, hospitalization, and need of personal assistance for toilet visits.
CONTEXT: For patients in palliative care, constipation is primarily a result of opioid treatment. Impacts from other factors related to constipation in palliative care are rarely studied. OBJECTIVES: The aim was to identify factors related to constipation in patients in palliative care, and then to compare these factors between patients with different types of constipation and patients without constipation. METHODS: Cross-sectional data on constipation was collected with a 26-item questionnaire from 485 patients in 38 specialist palliative care units in Sweden. Three different constipation groups were used; MC ONLY, PC ONLY, and MC & PC. Logistic regression analyses were used to calculate odds ratios. RESULTS:Patients with <3 defecations/week, MC ONLY, (n = 36) had higher odds of being hospitalized, bed-restricted, in need of personal assistance for toilet visits, and of having a poor fluid intake. Patients with the perception of being constipated, PC ONLY, (n = 93) had higher odds of having poor appetite, hemorrhoids, hard stool, more opioid treatment, less laxative treatment and of being more dissatisfied with constipation information. Patients with both <3 defecations/week and a perception of being constipated, MC & PC, (n = 78) had higher odds of having cancer- disease. CONCLUSION: There were several significant factors related to constipation with higher odds than opioid- treatment, for patients in palliative care, such as; hard stool, cancer diagnosis, dissatisfaction with information, low fluid intake, hemorrhoids, bed restriction, hospitalization, and need of personal assistance for toilet visits.
Authors: Tora S Solheim; David Blum; Peter M Fayers; Marianne J Hjermstad; Guro B Stene; Florian Strasser; Stein Kaasa Journal: Acta Oncol Date: 2013-09-02 Impact factor: 4.089
Authors: B Vellas; H Villars; G Abellan; M E Soto; Y Rolland; Y Guigoz; J E Morley; W Chumlea; A Salva; L Z Rubenstein; P Garry Journal: J Nutr Health Aging Date: 2006 Nov-Dec Impact factor: 4.075
Authors: R K Portenoy; H T Thaler; A B Kornblith; J M Lepore; H Friedlander-Klar; E Kiyasu; K Sobel; N Coyle; N Kemeny; L Norton Journal: Eur J Cancer Date: 1994 Impact factor: 9.162
Authors: Paola Iovino; Giuseppe Chiarioni; Giancarlo Bilancio; Massimo Cirillo; Igor B Mekjavic; Rado Pisot; Carolina Ciacci Journal: PLoS One Date: 2013-08-20 Impact factor: 3.240
Authors: Felicity Hasson; Deborah Muldrew; Emma Carduff; Anne Finucane; Lisa Graham-Wisener; Phil Larkin; Noleen Mccorry; Paul Slater; Sonja McIlfatrick Journal: Palliat Med Date: 2019-12-23 Impact factor: 4.762